In response to the COVID-19 health issue, we are offering telehealth as well as in-person appointments. Click to learn more.
We encourage you to review the information on this page about the UroLift procedure.
If you have questions, would like to learn more or wish to schedule a consultation with a Urolift physician, please contact our Patient Navigator, Tarra Putnam by clicking on the button below.
When is this treatment appropriate?
Medications may be the first course of treatment for an enlarged prostate. If medications do not provide enough symptom relief, if side effects are bothersome or if prescriptions become too expensive, some men choose an alternative treatment.
The UroLift System has 100% national Medicare coverage and is covered by most major private payors; however, The Urology Group will verify your coverage before you get the procedure.
The International Prostate Symptom Score (IPSS) questionnaire was developed to measure the severity of your BPH symptoms. Your score is not meant to provide medical advice or replace your doctor’s expert opinion and care. Only your doctor can diagnose whether you have BPH and assess your individual condition. There are other conditions that can cause urinary symptoms besides BPH.
Your score may indicate BPH if you:
When you get to your visit, you will be given a score sheet to complete. To view the score sheet, click here.
Typically, no overnight stay and no catheter is required but patients may experience urinary discomfort during the recovery period. Your urologist will talk with you about how quickly you can return to your daily activities.
Patients may experience improvement in their lower urinary tract symptoms as early as two weeks after the procedure.
With UroLift, patients have less downtime and experience very few, if any, side effects, especially in terms of sexual function.
Patients may experience some urinary discomfort during the recovery period. The most common side effects may include blood in the urine, some pain or discomfort when urinating, some increased urge to go, and discomfort in the pelvis. These symptoms typically resolve within two to four weeks after the procedure.
Is the treatment permanent?
The implants are intended to be permanent. The implant is made up of standard surgical implantable materials: a nitinol capsular tab, a stainless-steel urethral tab, and polyethylene suture that holds the two tabs together. Your doctor can remove the urethral implant, if needed. The suture can be cut and the urethral endpiece can be retrieved with a standard grasper. The capsular tab will remain in place inside the body.
How it Works
The UroLift® System is a treatment for benign prostatic hyperplasia (BPH).
The physician places small, permanent implants into the prostate to lift and hold enlarged tissue out of the way. This relieves pressure on the urethra and allows urine to flow. In a way, the implants act like curtain ties, lifting the tissue out of the way.
This minimally invasive procedure involves no cutting, heating or removal of prostate tissue. Your urologist will perform the procedure at our outpatient surgery center in Norwood.
Nearly all of our physicians can complete the UroLift treatment; however, some perform the procedure more often than others.
Those physicians include:
Dr. Aaron Bey
Dr. Brooke Edwards
Dr. Ryan Flynn
Dr. Stephen Kappa
Dr. Michael Rousseau
UroLift Patient Navigator